LNTH
Lantheus Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 127 | +5 | 56.13M | $5.57B | +13 | −9 |
| Q1 2026 | 126 | +6 | 62.19M | $3.90B | +10 | −5 |
| Q4 2025 | 120 | -2 | 60.97M | $3.47B | +2 | −3 |
| Q3 2025 | 20 | +2 | 33.16M | $1.70B | +2 | −1 |
| Q2 2025 | 16 | -2 | 29.15M | $2.39B | +1 | −3 |
| Q1 2025 | 15 | 0 | 7.80M | $761.04M | n/a | n/a |
| Q4 2024 | 15 | 0 | 6.76M | $604.90M | +2 | −2 |
| Q3 2024 | 14 | 0 | 4.84M | $531.32M | +1 | −1 |
| Q2 2024 | 14 | n/a | 5.72M | $459.02M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.65M | n/a | $132.58M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | T. Rowe Price ✦ | 1.24M | n/a | $99.61M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 746.85K | n/a | $59.96M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 475.60K | n/a | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 395.77K | n/a | $31.78M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | Point72 Asset Management ✦ | 333.72K | n/a | $26.79M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 302.97K | n/a | $24.33M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Renaissance Technologies ✦ | 215.43K | n/a | $17.30M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 156.80K | n/a | $12.59M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 109.13K | n/a | $8.76M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 33.92K | n/a | $2.72M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 31.47K | n/a | $2.53M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | Gotham Asset Management ✦ | 15.12K | n/a | $1.21M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 8.33K | n/a | $668,494 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 401 holders, 70.59M shares, $5.23B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.